{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:46:21Z","timestamp":1792788381619,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Innovative and Entrepreneurial Talent Program","award":["JSSCBS20211493"],"award-info":[{"award-number":["JSSCBS20211493"]}]},{"name":"the National Natural Science Foundation of China","award":["82330055"],"award-info":[{"award-number":["82330055"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Joint Fund of the National Natural Science Foundation of China","award":["U24A20380"],"award-info":[{"award-number":["U24A20380"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05167-2","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:21:37Z","timestamp":1783678897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allogeneic mesenchymal stromal cells ameliorate lupus nephritis by regulating lipid metabolism via ASGR1"],"prefix":"10.1186","volume":"17","author":[{"given":"Yujiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"10188","key":"5167_CR1","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393(10188):2332\u201343.","journal-title":"Lancet"},{"issue":"11","key":"5167_CR2","doi-asserted-by":"publisher","first-page":"Itc81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL. Systemic Lupus Erythematosus. Ann Intern Med. 2020;172(11):Itc81\u201396.","journal-title":"Ann Intern Med"},{"issue":"6","key":"5167_CR3","doi-asserted-by":"publisher","first-page":"Itc81","DOI":"10.7326\/AITC202306200","volume":"176","author":"M Arvanitis","year":"2023","unstructured":"Arvanitis M, Lowenstein CJ, Dyslipidemia. Ann Intern Med. 2023;176(6):Itc81\u201396.","journal-title":"Ann Intern Med"},{"issue":"4","key":"5167_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1210\/endrev\/bnab037","volume":"43","author":"AJ Berberich","year":"2022","unstructured":"Berberich AJ, Hegele RA. A Modern Approach to Dyslipidemia. Endocr Rev. 2022;43(4):611\u201353.","journal-title":"Endocr Rev"},{"issue":"6","key":"5167_CR5","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s10067-023-06539-2","volume":"42","author":"S Huang","year":"2023","unstructured":"Huang S, Zhang Z, Cui Y, Yao G, Ma X, Zhang H. Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus. Clin Rheumatol. 2023;42(6):1565\u201372.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"5167_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","volume":"21","author":"J Luo","year":"2020","unstructured":"Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21(4):225\u201345.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"24","key":"5167_CR7","doi-asserted-by":"publisher","first-page":"11825","DOI":"10.1016\/S0021-9258(18)60888-9","volume":"262","author":"J Bischoff","year":"1987","unstructured":"Bischoff J, Lodish HF. Two asialoglycoprotein receptor polypeptides in human hepatoma cells. J Biol Chem. 1987;262(24):11825\u201332.","journal-title":"J Biol Chem"},{"issue":"14","key":"5167_CR8","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.3390\/ijms21144818","volume":"21","author":"JK Hoober","year":"2020","unstructured":"Hoober JK. ASGR1 and Its Enigmatic Relative, CLEC10A. Int J Mol Sci. 2020;21(14):4818.","journal-title":"Int J Mol Sci"},{"key":"5167_CR9","doi-asserted-by":"publisher","first-page":"117488","DOI":"10.1016\/j.biopha.2024.117488","volume":"180","author":"J Song","year":"2024","unstructured":"Song J, Fang Y, Rao X, Wu L, Zhang C, Ying J, et al. Beyond conventional treatment: ASGR1 Leading the new era of hypercholesterolemia management. Biomed Pharmacother. 2024;180:117488.","journal-title":"Biomed Pharmacother"},{"issue":"22","key":"5167_CR10","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1056\/NEJMoa1508419","volume":"374","author":"P Nioi","year":"2016","unstructured":"Nioi P, Sigurdsson A, Thorleifsson G, Helgason H, Agustsdottir AB, Norddahl GL, et al. Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. N Engl J Med. 2016;374(22):2131\u201341.","journal-title":"N Engl J Med"},{"issue":"7922","key":"5167_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41586-022-05006-3","volume":"608","author":"JQ Wang","year":"2022","unstructured":"Wang JQ, Li LL, Hu A, Deng G, Wei J, Li YF, et al. Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion. Nature. 2022;608(7922):413\u201320.","journal-title":"Nature"},{"key":"5167_CR12","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2147\/IJN.S355366","volume":"17","author":"S Wang","year":"2022","unstructured":"Wang S, Lei B, Zhang E, Gong P, Gu J, He L, et al. Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics. Int J Nanomed. 2022;17:1757\u201381.","journal-title":"Int J Nanomed"},{"issue":"1","key":"5167_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13287-024-03885-z","volume":"15","author":"S Zhidu","year":"2024","unstructured":"Zhidu S, Ying T, Rui J, Chao Z. Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities. Stem Cell Res Ther. 2024;15(1):266.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"5167_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fcvm.2017.00032","volume":"22","author":"F Li","year":"2017","unstructured":"Li F, Guo X, Chen SY. Function and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis. Front Cardiovasc Med. 2017;22(4):32.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"5167_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"5167_CR16","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35(6):630\u201340.","journal-title":"Arthritis Rheum"},{"issue":"9 Suppl","key":"5167_CR17","first-page":"S139","volume":"23","author":"S Karr","year":"2017","unstructured":"Karr S. Epidemiology and management of hyperlipidemia. Am J Manag Care. 2017;23(9 Suppl):S139\u201348.","journal-title":"Am J Manag Care"},{"issue":"8","key":"5167_CR18","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/art.27548","volume":"62","author":"L Sun","year":"2010","unstructured":"Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H, et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010;62(8):2467\u201375.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5167_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13287-019-1538-9","volume":"11","author":"T Zhou","year":"2020","unstructured":"Zhou T, Liao C, Li HY, Lin W, Lin S, Zhong H. Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis. Stem Cell Res Ther. 2020;11(1):48.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"5167_CR20","first-page":"771","volume":"68","author":"SC Strom","year":"1982","unstructured":"Strom SC, Jirtle RL, Jones RS, Novicki DL, Rosenberg MR, Novotny A, et al. Isolation, culture, and transplantation of human hepatocytes. J Natl Cancer Inst. 1982;68(5):771\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5167_CR21","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.xpro.2020.100086","volume":"1","author":"M Charni-Natan","year":"2020","unstructured":"Charni-Natan M, Goldstein I. Protocol for Primary Mouse Hepatocyte Isolation. STAR Protoc. 2020;1(2):100086.","journal-title":"STAR Protoc"},{"issue":"10441","key":"5167_CR22","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1016\/S0140-6736(24)00398-2","volume":"403","author":"A Hoi","year":"2024","unstructured":"Hoi A, Igel T, Mok CC, Arnaud L. Systemic lupus erythematosus. Lancet. 2024;403(10441):2326\u201338.","journal-title":"Lancet"},{"issue":"32","key":"5167_CR23","doi-asserted-by":"publisher","first-page":"e30090","DOI":"10.1097\/MD.0000000000030090","volume":"101","author":"W Gou","year":"2022","unstructured":"Gou W, Tuo YH. Comparison of mortality and its causes in patients with complicated systemic lupus erythematosus on hemodialysis versus peritoneal dialysis: A meta-analysis. Med (Baltim). 2022;101(32):e30090.","journal-title":"Med (Baltim)"},{"issue":"4","key":"5167_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.18632\/aging.100738","volume":"7","author":"RA van der Heijden","year":"2015","unstructured":"van der Heijden RA, Sheedfar F, Morrison MC, Hommelberg PP, Kor D, Kloosterhuis NJ, et al. High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL\/6j mice. Aging. 2015;7(4):256\u201368.","journal-title":"Aging"},{"issue":"3","key":"5167_CR25","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/biof.2028","volume":"50","author":"M Ofosu-Boateng","year":"2024","unstructured":"Ofosu-Boateng M, Shaik F, Choi S, Ekuban FA, Gebreyesus LH, Twum E, et al. High-fat diet induced obesity promotes inflammation, oxidative stress, and hepatotoxicity in female FVB\/N mice. BioFactors. 2024;50(3):572\u201391.","journal-title":"BioFactors"},{"issue":"7","key":"5167_CR26","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/nu11071664","volume":"11","author":"H Nishi","year":"2019","unstructured":"Nishi H, Higashihara T, Inagi R. Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction. Nutrients. 2019;11(7):1664.","journal-title":"Nutrients"},{"issue":"3","key":"5167_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1172\/JCI71863","volume":"124","author":"S Khan","year":"2014","unstructured":"Khan S, Abu Jawdeh BG, Goel M, Schilling WP, Parker MD, Puchowicz MA, et al. Lipotoxic disruption of NHE1 interaction with PI(4,5)P2 expedites proximal tubule apoptosis. J Clin Invest. 2014;124(3):1057\u201368.","journal-title":"J Clin Invest"},{"issue":"5","key":"5167_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.kint.2016.06.013","volume":"90","author":"HH Szeto","year":"2016","unstructured":"Szeto HH, Liu S, Soong Y, Alam N, Prusky GT, Seshan SV. Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury. Kidney Int. 2016;90(5):997\u20131011.","journal-title":"Kidney Int"},{"key":"5167_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.bi.51.070182.002531","volume":"51","author":"G Ashwell","year":"1982","unstructured":"Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem. 1982;51:531\u201354.","journal-title":"Annu Rev Biochem"},{"issue":"43","key":"5167_CR30","doi-asserted-by":"publisher","first-page":"10009","DOI":"10.1021\/bi00495a001","volume":"29","author":"M Spiess","year":"1990","unstructured":"Spiess M. The asialoglycoprotein receptor: a model for endocytic transport receptors. Biochemistry. 1990;29(43):10009\u201318.","journal-title":"Biochemistry"},{"issue":"10","key":"5167_CR31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41569-022-00768-9","volume":"19","author":"K Huynh","year":"2022","unstructured":"Huynh K. ASGR1 inhibition stimulates cholesterol excretion. Nat Rev Cardiol. 2022;19(10):642.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"5167_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s43556-025-00321-3","volume":"6","author":"D Cui","year":"2025","unstructured":"Cui D, Yu X, Guan Q, Shen Y, Liao J, Liu Y, et al. Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets. Mol Biomed. 2025;6(1):72.","journal-title":"Mol Biomed"},{"issue":"12","key":"5167_CR33","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1161\/ATVBAHA.124.321076","volume":"44","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Jiang X, Wang W, Lei L, Sheng R, Li S, et al. ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet-Fed ApoE(-\/-) Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux. Arterioscler Thromb Vasc Biol. 2024;44(12):2428\u201349.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"5167_CR34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s12933-024-02507-5","volume":"23","author":"M Svecla","year":"2024","unstructured":"Svecla M, Moregola A, Dalt LD, Nour J, Baragetti A, Uboldi P, et al. ASGR1 deficiency improves atherosclerosis but alters liver metabolism in ApoE(-\/-) mice. Cardiovasc Diabetol. 2024;23(1):428.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"5167_CR35","doi-asserted-by":"publisher","first-page":"e000704","DOI":"10.1136\/lupus-2022-000704","volume":"9","author":"DL Kamen","year":"2022","unstructured":"Kamen DL, Wallace C, Li Z, Wyatt M, Paulos C, Wei C, et al. Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE. Lupus Sci Med. 2022;9(1):e000704.","journal-title":"Lupus Sci Med"},{"key":"5167_CR36","doi-asserted-by":"publisher","first-page":"728190","DOI":"10.3389\/fimmu.2021.728190","volume":"12","author":"A Li","year":"2021","unstructured":"Li A, Guo F, Pan Q, Chen S, Chen J, Liu HF, et al. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus. Front Immunol. 2021;12:728190.","journal-title":"Front Immunol"},{"issue":"7","key":"5167_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/stcltm\/szad032","volume":"12","author":"Z Cao","year":"2023","unstructured":"Cao Z, Wang D, Jing L, Wen X, Xia N, Ma W, et al. Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus. Stem Cells Transl Med. 2023;12(7):431\u201343.","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"5167_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011;13(4):376\u201388.","journal-title":"Cell Metab"},{"issue":"3","key":"5167_CR39","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","volume":"146","author":"TR Peterson","year":"2011","unstructured":"Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell. 2011;146(3):408\u201320.","journal-title":"Cell"},{"issue":"1","key":"5167_CR40","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41467-019-08585-4","volume":"10","author":"Y Han","year":"2019","unstructured":"Han Y, Hu Z, Cui A, Liu Z, Ma F, Xue Y, et al. Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene. Nat Commun. 2019;10(1):623.","journal-title":"Nat Commun"},{"issue":"2","key":"5167_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cell.2015.06.017","volume":"162","author":"W Palm","year":"2015","unstructured":"Palm W, Park Y, Wright K, Pavlova NN, Tuveson DA, Thompson CB. The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1. Cell. 2015;162(2):259\u201370.","journal-title":"Cell"},{"issue":"3","key":"5167_CR42","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cell.2017.09.046","volume":"171","author":"GA Wyant","year":"2017","unstructured":"Wyant GA, Abu-Remaileh M, Wolfson RL, Chen WW, Freinkman E, Danai LV, et al. mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient. Cell. 2017;171(3):642\u2013e654612.","journal-title":"Cell"},{"issue":"7300","key":"5167_CR43","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nature09076","volume":"465","author":"L Yu","year":"2010","unstructured":"Yu L, McPhee CK, Zheng L, Mardones GA, Rong Y, Peng J, et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature. 2010;465(7300):942\u20136.","journal-title":"Nature"},{"issue":"1","key":"5167_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10020-024-00866-z","volume":"30","author":"L Zhao","year":"2024","unstructured":"Zhao L, Tang S, Chen F, Ren X, Han X, Zhou X. Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis. Mol Med. 2024;30(1):96.","journal-title":"Mol Med"},{"issue":"5","key":"5167_CR45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41577-019-0124-9","volume":"19","author":"DG Russell","year":"2019","unstructured":"Russell DG, Huang L, VanderVen BC. Immunometabolism at the interface between macrophages and pathogens. Nat Rev Immunol. 2019;19(5):291\u2013304.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"5167_CR46","first-page":"658","volume":"42","author":"W Nagata","year":"2024","unstructured":"Nagata W, Takayama E, Nakagawa K, Koizumi A, Ohsawa Y, Goto H, et al. Treatment with lysophosphatidic acid improves glomerulonephritis through the suppression of macrophage activation in a murine model of systemic lupus erythematosus. Clin Exp Rheumatol. 2024;42(3):658\u201365.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"5167_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/metabo11030142","volume":"11","author":"C Hu","year":"2021","unstructured":"Hu C, Du Y, Xu X, Li H, Duan Q, Xie Z, et al. Lipidomics Revealed Aberrant Metabolism of Lipids Including FAHFAs in Renal Tissue in the Progression of Lupus Nephritis in a Murine Model. Metabolites. 2021;11(3):142.","journal-title":"Metabolites"},{"issue":"10","key":"5167_CR48","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.4049\/jimmunol.1100225","volume":"187","author":"E Titos","year":"2011","unstructured":"Titos E, Rius B, Gonz\u00e1lez-P\u00e9riz A, L\u00f3pez-Vicario C, Mor\u00e1n-Salvador E, Mart\u00ednez-Clemente M, et al. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol. 2011;187(10):5408\u201318.","journal-title":"J Immunol"},{"issue":"15","key":"5167_CR49","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1182\/blood-2012-04-423525","volume":"120","author":"J Dalli","year":"2012","unstructured":"Dalli J, Serhan CN. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood. 2012;120(15):e60\u201372.","journal-title":"Blood"},{"issue":"9","key":"5167_CR50","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1371\/journal.pone.0000941","volume":"2","author":"B Parekkadan","year":"2007","unstructured":"Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, Tilles AW, et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE. 2007;2(9):e941.","journal-title":"PLoS ONE"},{"issue":"3","key":"5167_CR51","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5009\/gnl18412","volume":"14","author":"SH Kang","year":"2020","unstructured":"Kang SH, Kim MY, Eom YW, Baik SK. Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives. Gut Liver. 2020;14(3):306\u201315.","journal-title":"Gut Liver"},{"issue":"1","key":"5167_CR52","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/jcmm.14788","volume":"24","author":"C Hu","year":"2020","unstructured":"Hu C, Wu Z, Li L. Pre-treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases. J Cell Mol Med. 2020;24(1):40\u20139.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"5167_CR53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.21037\/atm.2020.02.163","volume":"8","author":"YW Eom","year":"2020","unstructured":"Eom YW, Kang SH, Kim MY, Lee JI, Baik SK. Mesenchymal stem cells to treat liver diseases. Ann Transl Med. 2020;8(8):563.","journal-title":"Ann Transl Med"},{"issue":"4","key":"5167_CR54","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3350\/cmh.2021.0390","volume":"28","author":"Y Lee","year":"2022","unstructured":"Lee Y, Kim JH. The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology. Clin Mol Hepatol. 2022;28(4):706\u201324.","journal-title":"Clin Mol Hepatol"},{"key":"5167_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mam.2017.11.001","volume":"60","author":"PB Devhare","year":"2018","unstructured":"Devhare PB, Ray RB. Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis. Mol Aspects Med. 2018;60:115\u201322.","journal-title":"Mol Aspects Med"},{"issue":"11","key":"5167_CR56","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1111\/jcmm.13208","volume":"21","author":"G Lou","year":"2017","unstructured":"Lou G, Yang Y, Liu F, Ye B, Chen Z, Zheng M, et al. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. J Cell Mol Med. 2017;21(11):2963\u201373.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"5167_CR57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13287-019-1204-2","volume":"10","author":"X Rong","year":"2019","unstructured":"Rong X, Liu J, Yao X, Jiang T, Wang Y, Xie F. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt\/\u03b2-catenin pathway. Stem Cell Res Ther. 2019;10(1):98.","journal-title":"Stem Cell Res Ther"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05167-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05167-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05167-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:02:02Z","timestamp":1791176522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05167-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5167"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05167-2","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol of patients was reviewed and approved by the Ethics Committee of Nanjing Drum Tower Hospital (Approval No. 2024-1034-01), and written informed consent was obtained from all participants. All experimental protocols of mice were reviewed and approved by the Experimental Animal Ethics Committee of Nanjing Drum Tower Hospital (Approval No.2024AE01101). Title of the approved project for human and animal studies: research on the mechanism of MSCs in the treatment of lupus nephritis, human umbilical cord MSCs and exosomes for the treatment of lupus brain injury and abnormal glucose and lipid metabolism. All procedures pertaining to animal experimentation in this study were conducted in strict compliance with the updated United Kingdom Animals (Scientific Procedures) Act 1986 and European Union Directive 2010\/63\/EU.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"353"}}